Microsatellite instability (MSI) is a hallmark of mismatch repair (MMR) deficiency and characterizes a distinct subset of colorectal cancers (CRC). In parallel, telomere length dynamics have emerged as important contributors to genomic stability and tumorigenesis. However, the relationship between MSI status, MMR protein expression, and telomere maintenance remains poorly defined. This study aimed to investigate the association between MSI status and telomere length in CRC cell lines and to evaluate the expression of key MMR proteins (MLH1, MSH2, MSH6, PMS2) to elucidate molecular differences between MSI and microsatellite stable (MSS) phenotypes. A panel of CRC cell lines with known MSI and MSS statuses was used. Telomere length was quantified using real-time quantitative PCR (qPCR) based on the T/S ratio method. MSI status was confirmed via PCR using mononucleotide repeat markers. Western blotting was performed to assess protein expressions of MLH1, MSH2, MSH6, and PMS2. β-actin served as a loading control. qPCR analysis revealed that MSI cell lines exhibited significantly longer telomeres compared to MSS lines (P < 0.05). Western blot results showed reduced or absent expression of MLH1 and PMS2 in MSI cell lines, confirming MMR deficiency. In contrast, MSS cell lines maintained normal expression of all tested MMR proteins. These findings suggest a link between defective MMR function and altered telomere dynamics in MSI-CRC. MSI CRC cell lines exhibit telomere elongation and loss of key MMR proteins, highlighting distinct molecular features compared to MSS counterparts. These insights may inform future strategies for personalized CRC diagnostics and therapeutics, particularly in the context of telomere-targeted or immunomodulatory treatments.
Published in | Cancer Research Journal (Volume 13, Issue 2) |
DOI | 10.11648/j.crj.20251302.11 |
Page(s) | 23-29 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2025. Published by Science Publishing Group |
Colorectal Cancer, Telomere Length, Microsatellite Instability, Mismatch Repair Pathway, MMqPCR, Western Blotting, HRM Analysis
[1] | Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022; 72(1): 7-33. |
[2] | Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990; 61(5): 759-767. |
[3] | Yamagishi H, Kuroda H, Imai Y, Hiraishi H. Molecular pathogenesis of sporadic colorectal cancers. Chin J Cancer. 2016; 35: 4. |
[4] | Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology. 2010; 138(6): 2073-2087. e3. |
[5] | Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004; 96(4): 261-268. |
[6] | Dey P, Thiel KW, Reinicke KE, et al. The role of MSI in colorectal cancer immunotherapy. Front Oncol. 2023; 13: 1111323. |
[7] | Li GM. Mechanisms and functions of DNA mismatch repair. Cell Res. 2008; 18(1): 85-98. |
[8] | Lao VV, Grady WM. Epigenetics and colorectal cancer. Nat Rev Gastroenterol Hepatol. 2011; 8(12): 686-700. |
[9] | Hause RJ, Pritchard CC, Shendure J, Salipante SJ. Classification and characterization of microsatellite instability across 18 cancer types. Nat Med. 2016; 22(11): 1342-1350. |
[10] | de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 2018; 32(7-8): 527-540. |
[11] | Takagi S, Kinouchi Y, Hiwatashi N, et al. Relationship between microsatellite instability and telomere shortening in colorectal cancer. Jpn J Cancer Res. 2000; 1(4): 399-407. |
[12] | Bozzao C, Lastella P, Ponz de Leon M, et al. Microsatellite instability and reduced expression of hMSH2 and hMSH6 are associated with shorter telomeres in colorectal cancer. Genes Chromosomes Cancer. 2011; 50(7): 391-401. |
[13] | Armanios M, Blackburn EH. The telomere syndromes. Nat Rev Genet. 2012; 13(10): 693-704. |
[14] | Shay JW. Role of telomeres and telomerase in aging and cancer. Cancer Discov. 2016; 6(6): 584-593. |
[15] | Omori Y, Takagi S, Ohata K, et al. Alternative lengthening of telomeres frequently occurs in mismatch repair system-deficient colorectal cancer. Cancer Sci. 2009; 100(2): 413-418. |
[16] | Freshney RI. Culture of Animal Cells: A Manual of Basic Technique and Specialized Applications. 6th ed. Wiley-Liss; 2010. |
[17] | Sambrook J, Russell DW. Molecular Cloning: A Laboratory Manual. 3rd ed. Cold Spring Harbor Laboratory Press; 2001. |
[18] | Harlow E, Lane D. Using Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory Press; 2006. |
[19] | Hosen I, Rachakonda S, Heidenreich B, et al. A robust qPCR method for relative telomere length determination. Genes Chromosomes Cancer. 2015; 54(7): 517-526. |
[20] | Vasilishina AA, Voronina EN, Timoshenko AV, et al. Relative telomere length as a biomarker. J Clin Pathol. 2019; 72(9): 641-647. |
[21] | Raji G, Bajwa H, Hussain T, et al. High-resolution melting curve analysis for MSI detection in colorectal cancer. Mol Biol Rep. 2022; 49(6): 5039-5048. |
[22] | Suraweera N, Duval A, Reperant M, et al. Evaluation of tumor microsatellite instability using five quasi-monomorphic mononucleotide repeats and pentaplex PCR. Oncogene. 2002; 21(37): 6041-6047. |
[23] | Goel A, Nagasaka T, Arnold CN, et al. High-resolution analysis of DNA mismatch repair gene defects in colorectal cancer using microsatellite instability markers. Clin Cancer Res. 2010; 16(21): 5341-5350. |
[24] | Smith PK, Krohn RI, Hermanson GT, et al. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985; 150(1): 76-85. |
[25] | Jiricny J. The multifaceted mismatch-repair system. Nat Rev Mol Cell Biol. 2006; 7(5): 335-346. |
[26] | Vilar E, Gruber SB. Microsatellite instability in colorectal cancer—the stable evidence. Nat Rev Clin Oncol. 2010; 7(3): 153-162. |
[27] | Takagi S, Kinouchi Y, Hiwatashi N, et al. Short telomeres in the colonic mucosa of patients with ulcerative colitis. J Gastroenterol. 2000; 35(7): 556-560. |
[28] | de la Chapelle A. Microsatellite instability. N Engl J Med. 2003; 349(3): 209-210. |
[29] | Omori Y, Itakura M, Ohata K, et al. Reduced hTERT expression in MSI-high colorectal cancer. Cancer Lett. 2009; 275(2): 227-234. |
[30] | Dey P, Thiel KW, Reinicke KE, et al. The intersection of telomere biology and immune evasion in cancer: therapeutic implications. Trends Cancer. 2023; 9(1): 22-35. |
[31] | Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell. 1985; 43(2 Pt 1): 405-413. |
[32] | Barthel FP, Wei W, Tang M, et al. Systematic analysis of telomere length and somatic alterations in 31 cancer types. Nat Genet. 2017; 49(3): 349-357. |
APA Style
Moka, R., Upadhya, S. (2025). Telomere Elongation and Mismatch Repair Deficiency Distinguish MSI Colorectal Cancer Cell Lines. Cancer Research Journal, 13(2), 23-29. https://doi.org/10.11648/j.crj.20251302.11
ACS Style
Moka, R.; Upadhya, S. Telomere Elongation and Mismatch Repair Deficiency Distinguish MSI Colorectal Cancer Cell Lines. Cancer Res. J. 2025, 13(2), 23-29. doi: 10.11648/j.crj.20251302.11
@article{10.11648/j.crj.20251302.11, author = {Rajasekhar Moka and Shreya Upadhya}, title = {Telomere Elongation and Mismatch Repair Deficiency Distinguish MSI Colorectal Cancer Cell Lines }, journal = {Cancer Research Journal}, volume = {13}, number = {2}, pages = {23-29}, doi = {10.11648/j.crj.20251302.11}, url = {https://doi.org/10.11648/j.crj.20251302.11}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.crj.20251302.11}, abstract = {Microsatellite instability (MSI) is a hallmark of mismatch repair (MMR) deficiency and characterizes a distinct subset of colorectal cancers (CRC). In parallel, telomere length dynamics have emerged as important contributors to genomic stability and tumorigenesis. However, the relationship between MSI status, MMR protein expression, and telomere maintenance remains poorly defined. This study aimed to investigate the association between MSI status and telomere length in CRC cell lines and to evaluate the expression of key MMR proteins (MLH1, MSH2, MSH6, PMS2) to elucidate molecular differences between MSI and microsatellite stable (MSS) phenotypes. A panel of CRC cell lines with known MSI and MSS statuses was used. Telomere length was quantified using real-time quantitative PCR (qPCR) based on the T/S ratio method. MSI status was confirmed via PCR using mononucleotide repeat markers. Western blotting was performed to assess protein expressions of MLH1, MSH2, MSH6, and PMS2. β-actin served as a loading control. qPCR analysis revealed that MSI cell lines exhibited significantly longer telomeres compared to MSS lines (P < 0.05). Western blot results showed reduced or absent expression of MLH1 and PMS2 in MSI cell lines, confirming MMR deficiency. In contrast, MSS cell lines maintained normal expression of all tested MMR proteins. These findings suggest a link between defective MMR function and altered telomere dynamics in MSI-CRC. MSI CRC cell lines exhibit telomere elongation and loss of key MMR proteins, highlighting distinct molecular features compared to MSS counterparts. These insights may inform future strategies for personalized CRC diagnostics and therapeutics, particularly in the context of telomere-targeted or immunomodulatory treatments. }, year = {2025} }
TY - JOUR T1 - Telomere Elongation and Mismatch Repair Deficiency Distinguish MSI Colorectal Cancer Cell Lines AU - Rajasekhar Moka AU - Shreya Upadhya Y1 - 2025/05/29 PY - 2025 N1 - https://doi.org/10.11648/j.crj.20251302.11 DO - 10.11648/j.crj.20251302.11 T2 - Cancer Research Journal JF - Cancer Research Journal JO - Cancer Research Journal SP - 23 EP - 29 PB - Science Publishing Group SN - 2330-8214 UR - https://doi.org/10.11648/j.crj.20251302.11 AB - Microsatellite instability (MSI) is a hallmark of mismatch repair (MMR) deficiency and characterizes a distinct subset of colorectal cancers (CRC). In parallel, telomere length dynamics have emerged as important contributors to genomic stability and tumorigenesis. However, the relationship between MSI status, MMR protein expression, and telomere maintenance remains poorly defined. This study aimed to investigate the association between MSI status and telomere length in CRC cell lines and to evaluate the expression of key MMR proteins (MLH1, MSH2, MSH6, PMS2) to elucidate molecular differences between MSI and microsatellite stable (MSS) phenotypes. A panel of CRC cell lines with known MSI and MSS statuses was used. Telomere length was quantified using real-time quantitative PCR (qPCR) based on the T/S ratio method. MSI status was confirmed via PCR using mononucleotide repeat markers. Western blotting was performed to assess protein expressions of MLH1, MSH2, MSH6, and PMS2. β-actin served as a loading control. qPCR analysis revealed that MSI cell lines exhibited significantly longer telomeres compared to MSS lines (P < 0.05). Western blot results showed reduced or absent expression of MLH1 and PMS2 in MSI cell lines, confirming MMR deficiency. In contrast, MSS cell lines maintained normal expression of all tested MMR proteins. These findings suggest a link between defective MMR function and altered telomere dynamics in MSI-CRC. MSI CRC cell lines exhibit telomere elongation and loss of key MMR proteins, highlighting distinct molecular features compared to MSS counterparts. These insights may inform future strategies for personalized CRC diagnostics and therapeutics, particularly in the context of telomere-targeted or immunomodulatory treatments. VL - 13 IS - 2 ER -